GlaxoSmithKline Consumer Healthcare has informed that a meeting of the Board of Directors will be held on November 01, 2018, to consider and take on record the Unaudited Financial Results for the Second Quarter ended September 30, 2018 with Limited Review by Auditors (Q2).
The above information is a part of company’s filings submitted to BSE.